Investing Profile

Niall O’Donnell

InvestorVC

Managing Director at RiverVest Venture Partners

Photo of Niall O’Donnell, Managing Director at RiverVest

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
RiverVest Managing Director
$100K - $1M
$100K
10
$184.4M
CompanyStageDateRound SizeTotal Raised
Glycomine
Series BJun 2021$35M
$35M
Reneo Pharmaceuticals
Series BDec 2020$95M
Series AMay 2019$50M
$145M
Co-investors: Ed Mathers (New Enterprise Associates (NEA))
Mirum Pharmaceuticals
Series ANov 2018$120M
$120M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Jonathan Leff (Deerfield Management)
Amplyx Pharmaceuticals
Series BNov 2015$40.5M
$40.5M
Co-investors: Alex Kahn (Generation Ventures)
Otonomy
Series DApr 2014$49M
Series CSep 2013$45.9M
Series BAug 2010$38.5M
$143.4M
Co-investors: John McKearn (RiverVest), Jay Lichter (Avalon Ventures), Heather Preston (Broadway Angels)
Lumena Pharmaceuticals
Series BMar 2014$45M
Series AMay 2013$23M
$68M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), John McKearn (RiverVest)